Intravenous Chemotherapy, Early Debulking Surgery, and Consolidation Intraperitoneal Chemotherapy in Advanced Ovarian Carcinoma

This publication has 17 references indexed in Scilit:

• Does Debulking Surgery Improve Survival in Biologically Aggressive Ovarian Carcinoma?
  Gynecologic Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer
  New England Journal of Medicine, 1995
• Impact of doxorubicin on survival in advanced ovarian cancer.
  Journal of Clinical Oncology, 1995
• The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer
  Gynecologic Oncology, 1995
• Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on Survival
  Gynecologic Oncology, 1993
• The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
  Gynecologic Oncology, 1992
• Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer
  European Journal Of Cancer, 1992
• Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1991
• A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives
  European Journal of Cancer and Clinical Oncology, 1989